Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

George Perry

Showing results (421-430 of 628) with videos related to

Pageof 63
Sort By:
CNS & Neurological Disorders Drug Targets|February 22, 2008
Alzheimer disease and the role of free radicals in the pathogenesis of the diseasePaula I Moreira, Maria S Santos, Catarina R Oliveira, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 7, 2002
Labeling of cerebral amyloid beta deposits in vivo using intranasal basic fibroblast growth factor and serum amyloid P component in miceJiong Shi, George Perry, Marc S Berridge, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|March 27, 2003
Apoptotic promoters and inhibitors in Alzheimer's disease: Who wins out?Arun K Raina, Ayala Hochman, Harold Ickes, et al.
Human Molecular Genetics|January 10, 2012
LRRK2 regulates mitochondrial dynamics and function through direct interaction with DLP1Xinglong Wang, Michael H Yan, Hisashi Fujioka, et al.
Translational Neurodegeneration|June 2, 2015
Posttranslational modifications of α-tubulin in alzheimer diseaseFan Zhang, Bo Su, Chunyu Wang, et al.
Neuro-Signals|February 5, 2003
Differential regulation of glutamate receptors in Alzheimer's diseaseHyoung-gon Lee, Xiongwei Zhu, Hossein A Ghanbari, et al.
The Journal of Biological Chemistry|February 12, 2004
Luteinizing hormone, a reproductive regulator that modulates the processing of amyloid-beta precursor protein and amyloid-beta depositionRichard L Bowen, Giuseppe Verdile, Tianbing Liu, et al.
Neurobiology of Disease|September 8, 2004
Neuronal RNA oxidation is a prominent feature of familial Alzheimer's diseaseAkihiko Nunomura, Shigeru Chiba, Carol F Lippa, et al.
Current Pharmaceutical Design|February 14, 2006
The cell cycle and hormonal fluxes in Alzheimer disease: a novel therapeutic targetKate M Webber, Gemma Casadesus, Xiongwei Zhu, et al.
Journal of Alzheimer'S Disease : JAD|March 23, 2018
Rab10 Phosphorylation is a Prominent Pathological Feature in Alzheimer's DiseaseTingxiang Yan, Luwen Wang, Ju Gao, et al.
Pageof 63

Showing results (421-430 of 628) with videos related to

Sort By:
Pageof 63
CNS & Neurological Disorders Drug Targets|February 22, 2008
Alzheimer disease and the role of free radicals in the pathogenesis of the diseasePaula I Moreira, Maria S Santos, Catarina R Oliveira, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 7, 2002
Labeling of cerebral amyloid beta deposits in vivo using intranasal basic fibroblast growth factor and serum amyloid P component in miceJiong Shi, George Perry, Marc S Berridge, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|March 27, 2003
Apoptotic promoters and inhibitors in Alzheimer's disease: Who wins out?Arun K Raina, Ayala Hochman, Harold Ickes, et al.
Human Molecular Genetics|January 10, 2012
LRRK2 regulates mitochondrial dynamics and function through direct interaction with DLP1Xinglong Wang, Michael H Yan, Hisashi Fujioka, et al.
Translational Neurodegeneration|June 2, 2015
Posttranslational modifications of α-tubulin in alzheimer diseaseFan Zhang, Bo Su, Chunyu Wang, et al.
Neuro-Signals|February 5, 2003
Differential regulation of glutamate receptors in Alzheimer's diseaseHyoung-gon Lee, Xiongwei Zhu, Hossein A Ghanbari, et al.
The Journal of Biological Chemistry|February 12, 2004
Luteinizing hormone, a reproductive regulator that modulates the processing of amyloid-beta precursor protein and amyloid-beta depositionRichard L Bowen, Giuseppe Verdile, Tianbing Liu, et al.
Neurobiology of Disease|September 8, 2004
Neuronal RNA oxidation is a prominent feature of familial Alzheimer's diseaseAkihiko Nunomura, Shigeru Chiba, Carol F Lippa, et al.
Current Pharmaceutical Design|February 14, 2006
The cell cycle and hormonal fluxes in Alzheimer disease: a novel therapeutic targetKate M Webber, Gemma Casadesus, Xiongwei Zhu, et al.
Journal of Alzheimer'S Disease : JAD|March 23, 2018
Rab10 Phosphorylation is a Prominent Pathological Feature in Alzheimer's DiseaseTingxiang Yan, Luwen Wang, Ju Gao, et al.
Pageof 63